Thermo Fisher Scientific (TMO) July 26 weekly option implied volatility into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Thermo Fisher Scientific (TMO) PT Raised to $655 at Jefferies
July 24, 2024 4:04 PM EDTJefferies analyst Brandon Couillard raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $655.00 (from $650.00) while maintaining a Buy rating.
The analyst comments "TMO delivered solid revenue/EPS upside despite the still choppy demand backdrop. FY guidance was nudged... More
Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'
July 24, 2024 12:39 PM EDTRBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) while maintaining a Outperform rating.
The analyst comments "Since taking over as the leader of TMO in 2009, CEO Marc Caspar (by our math) has hit or... More
Goldman Sachs Reiterates Buy Rating on Thermo Fisher Scientific (TMO)
July 24, 2024 7:15 AM EDTGoldman Sachs analyst Matthew Sykes reiterated a Buy rating and $650.00 price target on Thermo Fisher Scientific (NYSE: TMO).
The analyst comments "2Q24 bottom line beat with (1%) in organic growth: 2Q revenue of $10.54bn is above Visible Alpha Consensus Data of $10.52bn... More
